
Patient involvement in clinical trials is crucial to our community. The first ever clinical trial for MOG-AD was announced in October of 2021! As research moving forward, there will be more clinical trials in the near future.
Please Keep checking all trial links as sites are continually being identified
CosMOG
Sponsored by UCB Biopharma SRL
Learn more about the study from the CosMOG website.
UPDATE: 1/18/2023
They are working hard to open more sites worldwide that will be participating in the trial. While this has not completed, the trial is open for recruiting for 24 available sites. Thank you for your patience and stay tuned!
Meteoroid
Sponsored by Hoffmann-La Roche
Learn more about the study from the Meteoroid website.
Tolerization
While not yet a clinical trial, one of the most exciting areas of research is Tolerization for the MOG antibody. It is also being looked at for the AQP-4 antibody as well, which is detectable in many NMOSD patients.
The Guthy-Jackson Charitable Foundation has this page on the subject. We share this with you so that you can watch as this area of research develops:
It is hoped that this will trnaslate to clinical trials in the near future.